1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Susan E. Bates: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma Bethanechol, Gemcitabine, nab-paclitaxel - Pancreas Cancer | Phase 2 | Recruiting | Susan E. Bates | 37 | 2022-02-01 | 2025-06-05 |
| Azacitidine and Pembrolizumab in Pancreatic Cancer Pembrolizumab, Azacitidine - Pancreas Cancer | Phase 2 | Completed | Susan E. Bates | 36 | 2017-10-01 | 2026-01-27 |
Pancreatic Neoplasms (2) · Adenocarcinoma (1)
130-nm albumin-bound paclitaxel (1) · Azacitidine (1) · Bethanechol (1) · Gemcitabine (1) · pembrolizumab (1)
United States (2)